Speech of Kids After Neonatal Encephalopathy

Recruiting Observational Study
HIE - Hypoxic - Ischemic Encephalopathy Language Delay Autism ADHD - Attention Deficit Disorder With Hyperactivity Specific Language Impairment Intellectual Developmental Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
0 – 7
Sex
Any
Study type
Observational
Participants needed
93 (estimated)
Sponsor
Semmelweis University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this ambispective cohort study is to reveal the early indicators of delayed language development in children born with hypoxic-ischemic encephalopathy (HIE). We will examine the prognostic accuracy of different biomarkers, with a special focus on the ADC values of the corpus callosum. The main questions it aims to answer are: 1. To what extent does hypoxic-ischemic encephalopathy (H…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Children born between 2017 and 2023 with moderate to severe HIE, treated with therapeutic hypothermia at Semmelweis University Children's Hospital. Inclusion criteria 1. Born at ≥ 35th week of gestation 2. Attended follow-up examinations at two years of age 3. Has parental informed consent Exclus…
Contacts

No contact information available.